Table 1.
Baseline characteristics of the patients enrolled in the study.
| Characteristic | Treatment group (n = 10) | Control group (n = 10) | Difference |
|
|---|---|---|---|---|
| P-value | ||||
| Age (years) | 58.90 (8.28) | 59.7 (15.82) | 0.89 | |
| Gender, male/female | 8/2 | 6/4 | 0.33 | |
| Time from stroke onset (days) | 922.30 (693.95) | 1,195.7 (1546.48) | 0.62 | |
| Affected side, right/left | 5/5 | 5/5 | 1.00 | |
| Hand dominance, right/left | 10/0 | 9/1 | 0.30 | |
| Stroke type, hemorrhage/infarction | 4/6 | 2/8 | 0.33 | |
| Site of lesion | Putamen | 3 | 3 | |
| Prefrontal cortex | 2 | 3 | ||
| Corona radiata | 1 | 1 | ||
| Thalamus | 3 | 2 | ||
| Internal capsule | 1 | 1 | ||
| Upper extremity score via FMA | 43.00 (9.82) | 44.00 (8.01) | 0.81 | |
| AOU score via MAL | 1.51 (0.78) | 1.42 (0.79) | 0.80 | |
| QOM score via MAL | 1.55 (0.77) | 1.36 (0.71) | 0.57 |
Data shown as average (SD) or number of observations.
AOU, amount of use; FMA, Fugl-Meyer Assessment; MAL, Motor Activity Log; QOM, quality of movement.